Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Head & Neck|November 10, 2020
Therapeutic implications of immune-profiling and EGFR expression in salivary gland carcinomaEmily Guazzo, Caroline Cooper, Lisa Wilkinson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 5, 2015
Predicting the need for adaptive radiotherapy in head and neck cancerElizabeth Brown, Rebecca Owen, Fiona Harden, et al.
Head & Neck|October 2, 2004
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neckRobert E Ware, Jane P Matthews, Rodney J Hicks, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
NPJ Precision Oncology|March 20, 2021
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinomaCorey Smith, Margaret McGrath, Michelle A Neller, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary AnalysisLachlan McDowell, Mathias Bressel, Madeleine T King, et al.
American Journal of Clinical Oncology|February 4, 2015
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation OncologistsStephen L Lewis, Sandro Porceddu, Naoki Nakamura, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Comparison of Prophylactic Versus Reactive Tube Feeding Approaches on Weight Loss and Unplanned Hospital Admissions in Patients with Head and Neck Cancer Receiving ChemoradiotherapyTeresa Brown, Louise Cooney, David Smith, et al.
Oral Oncology|September 5, 2020
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group studyRichard J Young, Benjamin Solomon, June Corry, et al.
The Journal of Experimental Medicine|July 28, 2020
Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patientsKunal H Bhatt, Michelle A Neller, Sriganesh Srihari, et al.
Pageof 8